WASHINGTON, March 17 /PRNewswire/ -- Alpharma Inc.

WASHINGTON, March 16 /PRNewswire-USNewswire/ -- American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today.

BRIDGEWATER, N.J., June 29 /PRNewswire/ -- Ask most parents of high school and college-age students and they'll tell you that their kids think they have all the answers to life's tough questions.

Apharma Inc.

TAMPA, Fla., May 8 /PRNewswire-FirstCall/ -- Alpharma Inc.